EU-SolidAct

EU-SolidAct is a multinational, European, Adaptive Platform Trial used for new clinical trials
targeting SARS-CoV-2 in short-term and other emerging infectious

[EU-SolidAct @EU_SolidAct]

EU-SolidAct is part of the EU-RESPONSE project who has received funding from the European Union’s Horizon 2020 Research and Innovation Program under grant agreement No 101015736. @EUScienceInnov

[Alain Amstutz🇨🇭🇱🇸 @AlAinAmstutz]

🆕#IPDMA on #JAKinhibitors in #COVID19 patients in🏥. Many trials were conducted, but several❓❔❓ unanswered -> https://t.co/J40VtD3Blt
In collaboration with @OCBE_UniOslo, @ClinEpiBasel, @Inserm, a patient representative, @EU_SolidAct and 10 other participating trial teams

[EU-SolidAct @EU_SolidAct]

Results of the Bari-SolidAct clinical trial, conducted in 14 European countries, have been published in Critical Care.
https://t.co/LCTBArJlJt
https://t.co/1C3nGyXzJl

[EU-SolidAct @EU_SolidAct]

DMC/DSMB members do very valuable and mostly unappreciated work in RCTs. Thank you very much drs. @stefano_vella, Du, Medaglini, Jacobs, vd Werf, Medaglini, @pocock_stuart, @phaikyeong, Barnes, Yeni and Collier for excellent work in our DMC!

[BerGenBio @BGenBio]

We’re pleased to announce that our lead candidate, #bemcentinib, has been selected for inclusion in a pan-European research project exploring potential treatments for hospitalised COVID-19 patients, the @EU_SolidAct trial.

Read the release here: https://t.co/mhL7gabBdp

#AXL

[EU-SolidAct @EU_SolidAct]

@BGenBio and @Oslounivsykehus announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded @EU_SolidAct trial in Hospitalised COVID-19 Patients
https://t.co/WGwHuaVSQI

@EUScienceInnov/@Inserm/@ECRIN_ERIC

[EU-SolidAct @EU_SolidAct]

Now Austria and and the Medical University of Innsbruck has included their first patient in the EU-SolidAct trial on Baricitinib treatment
@EUScienceInnov/@ECRIN_ERIC/@Oslounivsykehus/@Inserm

[EU-SolidAct @EU_SolidAct]

Happy to inform that we have now reached 200 randomised patients! We have opened 45 sites in 10 countries, with more to follow.
@EUScienceInnov
/
@ECRIN_ERIC
/
@Oslounivsykehus
/
@Inserm

[EU-SolidAct @EU_SolidAct]

Happy to inform that Belgium and Luxembourg have now included their first patients, making them the 6th and 7th country with more to come!

[Departement Klinische Forschung, Universität Basel @DKFBasel]

New paper from the DisCoVeRy and the @EU_SolidAct EU-RESPONSE group with @DKFBasel contribution by Matthias Briel: "Europe, despite its diversity, must be capable of responding unanimously and rapidly to any health crisis": https://t.co/kyZSMcfnTo
#platformtrial #COVID19

[EU-SolidAct @EU_SolidAct]

Happy to inform that we have now reached 100 randomised patients! We are recruiting in 33 sites in 5 countries, with more to follow.
@EUScienceInnov/@ECRIN_ERIC/@Oslounivsykehus/
@Inserm

[EU-SolidAct @EU_SolidAct]

Baricitinib/placebo has arrived @LovisenbergSH! @simenws and colleagues are ready to include their first patient in the Trial as the eight European site.

[EU-SolidAct @EU_SolidAct]

Happy to inform that the two first patients are included, the first at the world's northernmost university hospital @UNN_HF with PI A Kildal and the second in @SykehusVestfold with PI @dr_asgeir!
@EUScienceInnov / @ECRIN_ERIC / @Oslounivsykehus / @Inserm

[Oslounivsykehus @Oslounivsykehus]

Den nye Europeiske plattformstudien for COVID-19 og fremtidige pandemier, EU-SolidAct, har nå startet å inkludere pasienter ved norske sykehus. Studien skal gå i 15 land og ledes av OUS. https://t.co/Iw5hwQ6lZs /
@EU_SolidAct / @ECRIN_ERIC / @Inserm/ @EUScienceInnov

[Inge Christoffer Olsen @icostatistics]

@EU_SolidAct Baricitinib is in the house! Aleksander has everything ready and set to include the first patient!

[Oslounivsykehus @Oslounivsykehus]

EU SolidAct, a new platform trial for emerging pandemics, today starts testing new drugs for severe COVID-19, aiming to improve treatment options and to strengthen European pandemic preparedness https://t.co/Iw5hwQ6lZs / @EU_SolidAct / @ECRIN_ERIC / @Inserm / @EUScienceInnov